daraxonrasib
daraxonrasib is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including RASONQUE. Available dosage form: tablet, film coated.
Drug details
- Generic Name
- daraxonrasib
- Brand Names
- RASONQUE
- Application Number
- NDA220910
- Sponsor
- Revolution Medicines, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- DARAXONRASIB
Indications and Usage
1 INDICATIONS AND USAGE RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. RASONQUE is an inhibitor of the RAS GTPase family, indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. ( 1 )